Evaluation of inosin-5′-monophosphate dehydrogenase activity during maintenance therapy with tacrolimus

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 1, 2010, Pages 79-85

  Maiguma, T ^a   Yosida, T ^b   Otsubo, K ^b   Okabe, Y ^c   Sugitani, A ^c   Tanaka, M ^c   Oishi, R ^b   Teshima, D ^a  

^a SHUJITSU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

High performance liquid chromatography; Inosin 5 monophosphate dehydrogenase; Mycophenolic acid; Renal transplantation; Tacrolimus

Indexed keywords

CYCLOSPORIN A; INOSINATE DEHYDROGENASE; INOSINE PHOSPHATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE ADENINE DINUCLEOTIDE; PREDNISOLONE; PURINE DERIVATIVE; STEROID; TACROLIMUS; UNCLASSIFIED DRUG; XANTHOSINE PHOSPHATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MALE; PATIENT MONITORING; POSTOPERATIVE COMPLICATION;

ADULT; BIOMARKERS, PHARMACOLOGICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; KIDNEY TRANSPLANTATION; KINETICS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PRODRUGS; REPRODUCIBILITY OF RESULTS; RIBONUCLEOTIDES; TACROLIMUS; YOUNG ADULT;

EID: 74349085408     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01072.x     Document Type: Article

References (20)

1. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C (1997) Mycophenolate mofetil in renal allograft recipients. Transplantation, 63, 39 47.
2. Shaw LM, Kaplan B, DeNofrio D, Korecka M, Brayman KL (2000) Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Therapeutic Drug Monitoring, 22, 14 19.
3. Offermann G (2003) Five-year results of renal transplantation on immunosuppressive triple therapy with mycophenolate mofetil. Clinical Transplantation, 17, 43 46.
4. European Mycophenolate Mofetil Cooperative Study Group (1995) Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet, 345, 1321 1325.
5. Shaw LM, Nicholls A, Hale M, Armstrong VW, Oellerich M, Yatscoff R, Morris RE (1998) Therapeutic monitoring of mycophenolic acid - a consensus panel report. Clinical Biochemistry, 31, 317 322.
6. Mourad M, Malaise J, Eddour DC, Meyer MD, König J, Schepers R (2001) Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil. Clinical Chemistry, 47, 88 94.
7. Nicholls AJ (1998) Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokineticpharmacodynamic relationship for mycophenolic acid and suppression of rejection. Clinical Biochemistry, 31, 329 333.
8. Shaw LM, Holt DW, Oellerich M, Meiser B, Gelder TV (2001) Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Therapeutic Drug Monitoring, 23, 305 315.
9. Oellerich M, Shipkova M, Schütz E, Wieland E, Weber L, Tönshoff B, Armstrong VW (2000) Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. Therapeutic Drug Monitoring, 22, 20 26.
10. Langman LJ, LeGatt DF, Yatscoff RW (1995) Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity. Clinical Chemistry, 41, 295 299.
11. Albrecht W, Storck M, Pfetsch E, Martin W, Abendroth D (2000) Development and application of a high-performance liquid chromatography based assay for determination of the activity of inosine 5′-monophosphate dehydrogenase in whole blood and isolated mononuclear cells. Therapeutic Drug Monitoring, 22, 283 294.
12. Glander P, Braun KP, Hambach P et al. (2001) Non-radioactive determination of inosine 5′-monophosphate dehydrogenase (IMPDH) in peripheral mononuclear cells. Clinical Biochemistry, 34, 543 549.
13. Montero C, Duley JA, Fairbanks LD, McBride MB, Micheli V, Cant AJ, Morgan G (1995) Demonstration of induction of erythrocyte inosine monophosphate dehydrogenase activity in ribavirin-treated patients using a high performance liquid chromatography linked method. Clinical Chimica Acta, 238, 169 178.
14. Böyum A (1968) Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scandinavian Journal of Clinical and Laboratory Investigation, Supplement, 97, 77 89.
15. Daxecker H, Raab M, Müller MM (2002) Influence of mycophenolic acid on inosine 5′-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells. Clinical Chimica Acta, 318, 71 77.
16. Teshima D, Otsubo K, Kitagawa N, Yoshimura S, Itoh Y, Oishi R (2003) High-performance liquid chromatographic method for mycophenolic acid and its glucuronide in serum and urine. Journal of Clinical Pharmacy and Therapeutics, 28, 17 22.
17. Brunet M, Martorell J, Oppenheimer F et al. (2000) Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low dose of mycophenolate mofetil. Transplantation International, 13, S301 S305.
18. Budde K, Braun KP, Glander P et al. (2002) Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients. Transplantation Proceeding, 34, 1748 1750.
19. Braun KP, Glander P, Hambach P et al. (2002) Pharmacokinetics and pharmacodynamics of mycophenolate mofetil under oral and intravenous therapy. Transplantation Proceeding, 34, 1745 1747.
20. Langman LJ, LeGatt DF, Halloran PF, Yatscoff RW (1996) Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients. Transplantation, 62, 666 672.